Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11851
CALL
Solid Biosciences
SLDB
$986M
| $91.9K | ﹤0.01% |
14,900
-16,900
| -53% | -$98.8K |
|
11852
MediciNova
MNOV
$64.5M
| $91.8K | ﹤0.01% |
+72,897
| New | +$94.2K |
|
11853
InspireMD
NSPR
$46M
| $91.5K | ﹤0.01% |
37,954
+11,778
| +45% | +$28.6K |
|
11854
Recon Technology
RCON
$2.32M
| $91.3K | ﹤0.01% |
+46,134
| New | +$112K |
|
11855
PUT
Atea Pharmaceuticals
AVIR
$411M
| $91.1K | ﹤0.01% |
+31,400
| New | +$107K |
|
|
MVO
11856
CALL
DELISTED
MV Oil Trust
MVO
| $91K | ﹤0.01% |
+16,200
| New | +$95.1K |
|
|
FPAY
11857
DELISTED
FlexShopper
FPAY
| $90.9K | ﹤0.01% |
141,859
+113,060
| +393% | +$97.8K |
|
|
KREF
11858
PUT
KKR Real Estate Finance Trust
KREF
$490M
| $90.9K | ﹤0.01% |
10,100
-110,600
| -92% | -$1.03M |
|
11859
PUT
Vir Biotechnology
VIR
$1.56B
| $90.8K | ﹤0.01% |
15,900
-12,800
| -45% | -$65.5K |
|
|
TTSH
11860
CALL
DELISTED
Tile Shop Holdings
TTSH
| $90.8K | ﹤0.01% |
+15,000
| New | +$96.2K |
|
11861
Angel Oak Mortgage-Backed Securities ETF
MBS
$150M
| $90.6K | ﹤0.01% |
10,387
-4,348
| -30% | -$37.6K |
|
|
SLAI
11862
CALL
DELISTED
SOLAI Ltd ADS
SLAI
| $90.5K | ﹤0.01% |
+4,786
| New | +$100K |
|
|
TWNP
11863
DELISTED
Twin Hospitality Group
TWNP
| $90.3K | ﹤0.01% |
21,659
+10,409
| +93% | +$42K |
|
|
NFGC
11864
PUT
New Found Gold
NFGC
$649M
| $90.3K | ﹤0.01% |
38,100
+10,700
| +39% | +$18.8K |
|
|
11865
CALL
Atea Pharmaceuticals
AVIR
$411M
| $90.2K | ﹤0.01% |
+31,100
| New | +$106K |
|
11866
LGL Group
LGL
$93.6M
| $90.2K | ﹤0.01% |
+13,515
| New | +$94.2K |
|
11867
PUT
Ambev
ABEV
$43.2B
| $89.9K | ﹤0.01% |
+40,300
| New | +$92.2K |
|
|
EWCZ
11868
CALL
DELISTED
European Wax Center
EWCZ
| $89.8K | ﹤0.01% |
+22,500
| New | +$103K |
|
11869
CALL
Expensify
EXFY
$210M
| $89.7K | ﹤0.01% |
+48,500
| New | +$98.2K |
|
|
BZUN
11870
PUT
Baozun
BZUN
$165M
| $89.1K | ﹤0.01% |
22,000
-10,700
| -33% | -$34.7K |
|
11871
CALL
Funko
FNKO
$344M
| $89.1K | ﹤0.01% |
25,900
+14,100
| +119% | +$52.3K |
|
|
GENVR
11872
Gen Digital Inc Contingent Value Rights
GENVR
| $88.7K | ﹤0.01% |
12,724
+204
| +2% | +$1.84K |
|
|
TEI
11873
Templeton Emerging Markets Income Fund
TEI
$320M
| $88.7K | ﹤0.01% |
+14,302
| New | +$87.4K |
|
|
CCIF
11874
Carlyle Credit Income Fund
CCIF
$60.6M
| $88.5K | ﹤0.01% |
+15,213
| New | +$88.8K |
|
11875
PUT
Methode Electronics
MEI
$608M
| $88.3K | ﹤0.01% |
11,700
-13,400
| -53% | -$99.7K |
|
Similar funds
Ken Griffin's Q3 2025 Portfolio in Review
As of Q3 2025, Ken Griffin held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin's Q3 2025 filing shows 2,292 new, 5,364 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Ken Griffin's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Ken Griffin fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Ken Griffin's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Ken Griffin opened 2,292 new positions and closed 1,963 in Q3 2025.
- Ken Griffin's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.